Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.045 | 0.8 |
mRNA | ATRA | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.03 | 0.8 |
mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.012 | 0.8 |